Global Research Antibodies and Reagents Market

Research Anti-Bodies & Reagents Market Insights

The research antibodies and reagents market will strive to achieve unprecedented growth levels during the forecast period. Antibodies are classified as proteins that are secreted by the immune system whilst protecting the body from foreign bodies. Anti-bodies have varied uses in therapeutics, diagnostic tests, and basic research. The Invitrogen antibodies are primarily used and assigned to detect the targets. As the world moves towards unique drug discoveries, building infrastructure to enhance the customized research, the greater the need for research antibodies and reagents in the medical &biotechnology field. As the cancer rate and burden increases globally, the growing need for a range of high quality and innovative reagents is required to fasten the cancer research. As biotechnology and pharmaceutical companies’ progress in North America, Asia-Pacific, and the European region, the market for research antibodies and reagents would also grow potentially in the projected period.

Research Anti-Bodies & Reagents Market: By Product

The product segment includes reagents and antibodies. The antibodies segment is further sub-segmented into by source, by form, and by research areas. The research reagents have importance in cancer research and are constantly evolving to meet the needs of the pharmaceutical industry. The rising adoption of research reagents by bio-scientists will support the growth of the research reagents in the market. The antibodies from the point of view of research will act as the biggest market propeller owing to the rise in targeted research and methodologies.

Research Anti-Bodies & Reagents Market: By Technology

Western blotting, flow cytometry, immunofluorescence, immunoprecipitation, and enzyme-linked immunosorbent assay among others are included in the technology segment. The flow cytometry technique would register a high level of growth during the forecast period. this technique is extensively applied in the identification of specific diseases to varied cell types. flow cytometry has been exploited to diagnose lymphoma and leukemia.  The ability to detect cancers in early stages as compared to microscopic results makes the technique highly valuable in the market.

Research Anti-Bodies & Reagents Market: By Application

Drug development, genomics, and proteomics are the applications where research antibodies and reagents are used.  The proteomics segment would be trending upwards in the market. Due to the rising number of biomarkers generated by proteomic analyses, anti-bodies are considered as an excellent choice for target specificity, leading them to be the preferred choice in proteomics.

Research Anti-Bodies & Reagents Market: By End User

Based on the end-user, the market considers academic &research institutes, Pharmaceutical  & biotechnology companies, and contract research organization into being.  Pharmaceutical & biotechnology companies would occupy a fair share of the market.  Increasing R&D activities, a rising number of novel drug discoveries, and strategic collaborations among companies to enhance the market value would work as effective propellers of the market.

Research Anti-Bodies & Reagents Market: By Region

Based on the regional study, North America would be a dominating player in this market. Extensive research activities, rising cancer-related diseases in the region, and huge government funding for specific research in drug developments, genomics would propel the market to deepen its roots in the region.

However, on the contrary, the Asia Pacific region will be a hub of opportunities for the major players as its CAGR would be the highest, i.e. it would be growing the fastest amongst all. This is mainly due to the explicit healthcare industry, the high prevalence of lifestyle disorders, infectious diseases and chronic disorders, and rising research projects and activities related to advances in techniques of proteomic and genomic and attractive and supportive regulatory policies in this region.

Market share and Competitive Analysis

Key players operating in the market include Abcam Plc, GE Healthcare, Cell Signaling Technology, Inc, Santa Cruz Biotechnology, Inc, Thermo Fisher Scientific Inc, Rockland Immunochemicals Inc, Merck KGaA, Becton Dickinson and Company, Johnson & Johnson, CellMid, Opthea, Teva, Southern Biotech, Acyte Biotech, Gene Tex, Adanate, and Nano Smart Technologies among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In October 2020, Centivac Inc, a contract research organization announced a strategic agreement with Thermo Fisher Scientific to license the anti-covid-19 antibodies.

Check the Press Release on Global Research Antibodies and Reagents Market Report